Ontology highlight
ABSTRACT: Longitudinal omics data followed by preclinical treatment studies identify proteasome inhibition as potential salvage strategy for ibrutinib-resistant CLL
PROVIDER: PRJNA889569 | ENA |
REPOSITORIES: ENA
ACCESS DATA